Company
TriSalus Life Sciences, Inc.
TLSI · CIK 0001826667
Disposition (code F) of 2,693 shares at $4.38 per share.
Reporting Person Szela Mary T · Officer Title CEO and President · Transaction Code F
Traded Oct 5, 2026 · Disclosed Oct 7, 2026
Source: SEC Form 4 · 0001628280-26-065323 · filed 2026-10-07 · View filing →
Sale of 316 shares at $4.39 per share.
Reporting Person Stevens Jennifer · Officer Title Chief Regulatory Officer · Transaction Code S
Traded Oct 5, 2026 · Disclosed Oct 7, 2026
Source: SEC Form 4 · 0001628280-26-065324 · filed 2026-10-07 · View filing →
Sale of 325 shares at $4.39 per share.
Reporting Person Marshak Richard · Officer Title Chief Commercial Officer · Transaction Code S
Traded Oct 5, 2026 · Disclosed Oct 7, 2026
Source: SEC Form 4 · 0001628280-26-065325 · filed 2026-10-07 · View filing →
Sale of 296 shares at $4.39 per share.
Reporting Person Cox Bryan F. · Officer Title Chief of Research · Transaction Code S
Traded Oct 5, 2026 · Disclosed Oct 7, 2026
Source: SEC Form 4 · 0001628280-26-065326 · filed 2026-10-07 · View filing →